Author name: TB Alliance

The US-based Global Alliance for TB Drug Development, a one-year old private and public venture participation company has announced that

Several India pharma companies feature in the line up to develop new molecule for drug resistant tuberculosis, which is going

TB Alliance co-hosted a discussion of “Current Developments in Drug Discovery for Tuberculosis” organized by AstraZeneca Research Foundation-India. CEO Dr.

Once thought to be a disease of the past, tuberculosis is now a front burner health problem. With 8.4 million

New York, Jan. 1 – In his memoirs, Alexandre Dumas observed wryly that “it was all the fashion to suffer

2001 DEC 16 – Fueled by the growing tuberculosis epidemic, the market for drugs to treat TB will approach $700

Though not huge, size should draw interest, say authors An exhaustive new report on the size of the world market

The Global Alliance for TB Drug Development has published a report it believes will revive he interest of the pharmaceutical

The market for tuberculosis (TB) treatments will grow from between $412.5 and $470.5 million currently to between $612 and $670

According to a new report released by the Global Alliance for TB Drug Development, a non- profit organization created to